Two Sigma Investments, LP Actinium Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$7.15 - $9.39 $186,436 - $244,844	-26,075 Reduced 57.25%	19,468 $144,000
Q1 2023 May 15, 2023	SELL	$8.51 - $14.26 $1.43 Million - $2.39 Million	-167,777 Reduced 78.65%	45,543 $430,000
Q4 2022 Feb 14, 2023	BUY	$7.05 - $14.41 $1.39 Million - $2.85 Million	197,494 Added 1247.91%	213,320 $2.27 Million
Q3 2022 Nov 14, 2022	SELL	$4.81 - $8.48 $199,095 - $351,004	-41,392 Reduced 72.34%	15,826 $117,000
Q2 2022 Aug 15, 2022	BUY	$4.71 - $7.11 $269,496 - $406,819	57,218 New	57,218 $275,000

8.31M

65.2K

21.7K

Ticker ATNM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,184,700
Market Cap $28.2M
Description
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.